Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats.

Sabino JP, da Silva CA, Giusti H, Glass ML, Salgado HC, Fazan R Jr.

Auton Neurosci. 2013 Dec;179(1-2):43-8. doi: 10.1016/j.autneu.2013.07.001. Epub 2013 Aug 1.

2.

Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure.

Lataro RM, Silva CA, Fazan R Jr, Rossi MA, Prado CM, Godinho RO, Salgado HC.

Am J Physiol Regul Integr Comp Physiol. 2013 Oct 15;305(8):R908-16. doi: 10.1152/ajpregu.00102.2013. Epub 2013 Aug 15.

3.

Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats.

Soares PP, da Nóbrega AC, Ushizima MR, Irigoyen MC.

Auton Neurosci. 2004 Jun 30;113(1-2):24-31.

PMID:
15296792
4.

The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure.

Sabino JP, da Silva CA, de Melo RF, Fazan R Jr, Salgado HC.

Auton Neurosci. 2013 Jan;173(1-2):58-64. doi: 10.1016/j.autneu.2012.11.007. Epub 2012 Dec 4.

5.

Effect of chronic ethanol exposure on rat ventilatory responses to hypoxia and hypercapnia.

Sabino JP, Silva AL, Resstel LB, Antunes-Rodrigues J, Glass ML, Branco LG.

Clinics (Sao Paulo). 2014;69(5):360-6.

6.

Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: quantification by spectral analysis of heart rate fluctuations in healthy human beings.

Izraeli S, Alcalay M, Benjamini Y, Wallach-Kapon R, Tochner Z, Akselrod S.

Pharmacol Biochem Behav. 1991 Jul;39(3):613-7.

PMID:
1784590
7.

Cholinergic stimulation with pyridostigmine protects myocardial infarcted rats against ischemic-induced arrhythmias and preserves connexin43 protein.

Santos-Almeida FM, Girão H, da Silva CA, Salgado HC, Fazan R Jr.

Am J Physiol Heart Circ Physiol. 2015 Jan 15;308(2):H101-7. doi: 10.1152/ajpheart.00591.2014. Epub 2014 Nov 21.

8.

Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.

Behling A, Moraes RS, Rohde LE, Ferlin EL, Nóbrega AC, Ribeiro JP.

Am Heart J. 2003 Sep;146(3):494-500.

PMID:
12947369
9.

Heart rate variability in chronic heart failure: target for therapy?

Sueta CA.

Am Heart J. 2003 Sep;146(3):385-7. No abstract available.

PMID:
12947353
10.

Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.

Nóbrega AC, dos Reis AF, Moraes RS, Bastos BG, Ferlin EL, Ribeiro JP.

Clin Auton Res. 2001 Feb;11(1):11-7.

PMID:
11503945
11.

Chemoreflexes--physiology and clinical implications.

Kara T, Narkiewicz K, Somers VK.

Acta Physiol Scand. 2003 Mar;177(3):377-84. Review.

PMID:
12609009
12.

Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes.

Dewland TA, Androne AS, Lee FA, Lampert RJ, Katz SD.

Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H86-92. Epub 2007 Feb 23.

13.

Pyridostigmine prevents haemodynamic alterations but does not affect their nycthemeral oscillations in infarcted mice.

Corrêa WG, Durand MT, Becari C, Tezini GC, do Carmo JM, de Oliveira M, Prado CM, Fazan R Jr, Salgado HC.

Auton Neurosci. 2015 Jan;187:50-5. doi: 10.1016/j.autneu.2014.11.007. Epub 2014 Nov 21.

14.

Pyridostigmine enhances atrial tachyarrhythmias in aging spontaneously hypertensive rats.

Sayin H, Scridon A, Oréa V, Chapuis B, Chevalier P, Barrès C, Julien C.

Clin Exp Pharmacol Physiol. 2015 Oct;42(10):1084-91. doi: 10.1111/1440-1681.12458.

PMID:
26174159
15.

Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine.

Serra SM, Costa RV, Bastos BG, Bousquet Santos K, Ramalho SH, da Nóbrega AC.

Arq Bras Cardiol. 2001 Apr;76(4):279-84.

16.

Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.

Shaikh J, Karanth S, Chakraborty D, Pruett S, Pope CN.

Arch Toxicol. 2003 Oct;77(10):576-83. Epub 2003 Jul 29.

PMID:
14574445
17.

Pyridostigmine blunts the increases in myocardial oxygen demand elicited by the stimulation of the central nervous system in anesthetized rats.

Grabe-Guimarães A, Alves LM, Tibiriçá E, Nóbrega AC.

Clin Auton Res. 1999 Apr;9(2):83-9.

PMID:
10225612
18.

Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity.

Song X, Pope C, Murthy R, Shaikh J, Lal B, Bressler JP.

Toxicol Sci. 2004 Apr;78(2):241-7. Epub 2004 Feb 19.

PMID:
14976354
19.

Chronic cholinergic stimulation promotes changes in cardiovascular autonomic control in spontaneously hypertensive rats.

Blanco JH, Gastaldi AC, Gardim CB, Araujo JE, Simões MV, Oliveira LF, Carvalho EE, Souza HC.

Auton Neurosci. 2015 Dec;193:97-103. doi: 10.1016/j.autneu.2015.09.002. Epub 2015 Oct 21.

PMID:
26471065
20.

The effects of pyridostigmine bromide and permethrin, alone or in combination, on response acquisition in male and female rats.

Van Haaren F, Cody B, Hoy JB, Karlix JL, Schmidt CJ, Tebbett IR, Wielbo D.

Pharmacol Biochem Behav. 2000 Aug;66(4):739-46.

PMID:
10973511

Supplemental Content

Support Center